IDENTIFICATION OF POTENTIAL HLA-A-ASTERISK-0201 RESTRICTED CTL EPITOPES DERIVED FROM THE EPITHELIAL-CELL ADHESION MOLECULE (EP-CAM) AND THECARCINOEMBRYONIC ANTIGEN (CEA)
E. Ras et al., IDENTIFICATION OF POTENTIAL HLA-A-ASTERISK-0201 RESTRICTED CTL EPITOPES DERIVED FROM THE EPITHELIAL-CELL ADHESION MOLECULE (EP-CAM) AND THECARCINOEMBRYONIC ANTIGEN (CEA), Human immunology, 53(1), 1997, pp. 81-89
The altered expression pattern of the Epithelial Cell Adhesion Molecul
e (Ep-CAM) and the Carcinoembryonic Antigen (CEA) on tumor cells of ep
ithelial origin as compared to normal epithelia may permit T cells to
preferentially recognize and lyse these tumor cells. The binding affin
ity for human leucocyte antigen A2.1 (HLA-A0201) and the capacity to
form stable peptide-major histocompatibility complex (MHC) interaction
s with this molecule were tested for 410 Ep-CAM-derived sequences, inc
luding an overlapping set of 9 amino-acid-long peptides, and 73 CEA-de
rived peptides fulfilling the HLA-A0201 motif. Peptides with a high b
inding affinity and a low peptide-MHC dissociation rate were subsequen
tly tested for their immunogenicity in HLA-A0201K(b) transgenic mice.
One Ep-CAM-derived peptide and 1 CEA-derived peptide were able to rep
roducibly induce peptide-specific cytotoxic T cells (CTL) in these mic
e. This indicates that EpCAM and CEA are potential target antigens for
CTL-mediated immunotherapy of epithelial cancers. (C) American Societ
y for Histocompatibility and Immunogenetics, 1997.